Candriam Luxembourg S.C.A. increased its position in shares of Cigna Corporation (NYSE:CI) by 11.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,658 shares of the health services provider’s stock after buying an additional 1,819 shares during the period. Candriam Luxembourg S.C.A.’s holdings in Cigna Corporation were worth $2,956,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of CI. American Beacon Advisors Inc. bought a new stake in Cigna Corporation during the first quarter worth $102,000. Baystate Wealth Management LLC increased its stake in Cigna Corporation by 436.1% in the first quarter. Baystate Wealth Management LLC now owns 772 shares of the health services provider’s stock worth $116,000 after buying an additional 628 shares during the last quarter. Founders Capital Management bought a new stake in Cigna Corporation during the first quarter worth $117,000. Mckinley Capital Management LLC Delaware bought a new stake in Cigna Corporation during the first quarter worth $122,000. Finally, Guardian Life Insurance Co. of America increased its stake in Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock worth $145,000 after buying an additional 7 shares during the last quarter. Institutional investors and hedge funds own 87.61% of the company’s stock.
Shares of Cigna Corporation (NYSE CI) traded down 0.56% during trading on Friday, reaching $177.03. 1,034,361 shares of the company traded hands. The stock has a market capitalization of $44.57 billion, a P/E ratio of 20.43 and a beta of 0.46. The firm’s 50 day moving average is $173.66 and its 200-day moving average is $160.28. Cigna Corporation has a 12-month low of $115.03 and a 12-month high of $181.00.
Cigna Corporation (NYSE:CI) last announced its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.48 by $0.43. The business had revenue of $10.32 billion for the quarter, compared to analysts’ expectations of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The business’s revenue was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.98 earnings per share. On average, equities research analysts anticipate that Cigna Corporation will post $10.03 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Cigna Corporation (NYSE:CI) Shares Bought by Candriam Luxembourg S.C.A.” was originally posted by Rincon Hill News and is the property of of Rincon Hill News. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://rinconhillneighbors.org/2017/08/20/candriam-luxembourg-s-c-a-buys-1819-shares-of-cigna-corporation-nyseci-updated.html.
A number of brokerages have weighed in on CI. UBS AG reiterated a “buy” rating and set a $186.00 price target (up from $181.00) on shares of Cigna Corporation in a report on Monday, June 5th. ValuEngine upgraded Cigna Corporation from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Jefferies Group LLC reiterated a “buy” rating and set a $183.00 price target (up from $178.00) on shares of Cigna Corporation in a report on Friday, May 5th. Stifel Nicolaus increased their price target on Cigna Corporation from $170.00 to $175.00 and gave the stock a “buy” rating in a report on Friday, May 5th. Finally, Zacks Investment Research upgraded Cigna Corporation from a “hold” rating to a “buy” rating and set a $175.00 price target for the company in a report on Tuesday, April 25th. Three investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $180.44.
In other Cigna Corporation news, VP Mary T. Hoeltzel sold 525 shares of the company’s stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $177.59, for a total value of $93,234.75. Following the sale, the vice president now owns 1,924 shares in the company, valued at $341,683.16. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Mary T. Hoeltzel sold 500 shares of the company’s stock in a transaction dated Tuesday, June 6th. The stock was sold at an average price of $166.70, for a total transaction of $83,350.00. Following the completion of the sale, the vice president now owns 2,449 shares in the company, valued at approximately $408,248.30. The disclosure for this sale can be found here. In the last 90 days, insiders sold 243,463 shares of company stock worth $41,678,984. Corporate insiders own 1.30% of the company’s stock.
Cigna Corporation Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with our FREE daily email newsletter.